SSGJ-613

· Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SSGJ-613, covering 2024-08-05 to 2024-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment. [Phase 2]